 |
|  |
Nov-06-19 | Downgrade |
Janney |
Buy → Neutral |
|
|
Oct-18-19 | Upgrade |
UBS |
Neutral → Buy |
$14 → $7 |
|
Mar-15-19 | Initiated |
UBS |
Neutral |
$14 |
|
Jan-03-19 | Upgrade |
Janney |
Neutral → Buy |
|
|
Nov-02-18 | Upgrade |
Piper Jaffray |
Neutral → Overweight |
|
|
Aug-05-16 | Reiterated |
Mizuho |
Buy |
$11 → $12 |
|
Aug-05-16 | Reiterated |
Cantor Fitzgerald |
Buy |
$13 → $11 |
|
May-05-16 | Reiterated |
Mizuho |
Buy |
$8 → $11 |
|
Apr-12-16 | Reiterated |
Leerink Partners |
Outperform |
$20 → $15 |
|
Jan-07-16 | Initiated |
Deutsche Bank |
Buy |
$18 |
|
Oct-30-15 | Upgrade |
Cantor Fitzgerald |
Hold → Buy |
$15 → $12 |
|
Oct-30-15 | Reiterated |
Mizuho |
Neutral |
$15 → $8 |
|
Aug-27-15 | Initiated |
Cantor Fitzgerald |
Hold |
|
|
Aug-07-15 | Reiterated |
Mizuho |
Neutral |
$30 → $15 |
|
Aug-07-15 | Downgrade |
Piper Jaffray |
Overweight → Neutral |
|
|
May-08-15 | Reiterated |
Maxim Group |
Buy |
$52 → $44 |
|
May-08-15 | Downgrade |
Mizuho |
Buy → Neutral |
$50 → $30 |
|
May-06-14 | Reiterated |
Maxim Group |
Buy |
$65 → $52 |
|
Apr-23-14 | Upgrade |
Mizuho |
Neutral → Buy |
$43 → $50 |
|
Mar-21-14 | Reiterated |
Maxim Group |
Buy |
$52 → $65 |
|
|
 |
Nov-20-19 11:21AM | Fluidigm Corporation Announces Pricing of Private Offering of $50 Million of 5.25% Convertible Senior Notes GlobeNewswire |
06:36AM | Fluidigm Corporation Announces Proposed Private Offering of $45 Million of Convertible Senior Notes GlobeNewswire |
Nov-13-19 04:05PM | Fluidigm to Participate in the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire +5.49% |
Nov-10-19 03:29PM | Analysts See 2 Falling Knives Bouncing Back GuruFocus.com |
Nov-07-19 05:37PM | Edited Transcript of FLDM earnings conference call or presentation 5-Nov-19 10:00pm GMT Thomson Reuters StreetEvents |
Nov-05-19 07:55PM | Fluidigm (FLDM) Reports Q3 Loss, Misses Revenue Estimates Zacks |
04:05PM | Fluidigm Announces Third Quarter 2019 Financial Results GlobeNewswire |
04:02PM | Fluidigm Drives a New Standard in Human Immune Profiling GlobeNewswire |
Nov-01-19 08:17AM | Estimating The Fair Value Of Fluidigm Corporation (NASDAQ:FLDM) Simply Wall St. |
Oct-29-19 10:33AM | Fluidigm (FLDM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks |
Oct-28-19 08:23PM | Fluidigm Corporation (FLDM) Is Burning These Hedge Funds Insider Monkey |
Oct-15-19 04:15PM | Fluidigm Showcases RNA Sequencing Innovations Using Microfluidics Technology at the 2019 American Society of Human Genetics (ASHG) Meeting GlobeNewswire |
Oct-10-19 04:10PM | Fluidigm Announces Conference Call and Webcast of Third Quarter 2019 Financial Results GlobeNewswire |
Sep-26-19 09:16AM | Does Fluidigm Corporation's (NASDAQ:FLDM) CEO Salary Compare Well With Others? Simply Wall St. -5.02% |
Sep-24-19 08:30AM | Fluidigm Becomes the First Company to Enable 50-Plex Cytometry Panels with the Release of Seven New Metal Antibody Labels GlobeNewswire -6.47% |
Sep-18-19 08:30AM | CyTOF Inventors Receive Prestigious Science and Technology Award from the Human Proteome Organization (HUPO) GlobeNewswire |
Sep-10-19 07:30AM | Fluidigm Files Patent Infringement Suit Against IONpath GlobeNewswire |
Sep-09-19 08:30AM | Fluidigm Revolutionizes Next-Generation Sequencing RNA Library Preparation with Microfluidic Automation GlobeNewswire |
Sep-04-19 08:30AM | Fluidigm Launches Imaging Mass Cytometry Immuno-Oncology Panel Kits and Advanced CyTOF Software at the 2019 World Molecular Imaging Congress (WMIC) GlobeNewswire |
Aug-27-19 08:30AM | Fluidigm and the Icahn School of Medicine at Mount Sinai Collaborate on Landmark Single-Cell Study of the Human Epigenome GlobeNewswire |
Aug-21-19 07:48AM | Have Insiders Been Buying Fluidigm Corporation (NASDAQ:FLDM) Shares This Year? Simply Wall St. |
Aug-20-19 04:05PM | Fluidigm to Participate in Upcoming Health Care Investor Conferences GlobeNewswire |
Aug-05-19 05:44PM | Edited Transcript of FLDM earnings conference call or presentation 1-Aug-19 9:00pm GMT Thomson Reuters StreetEvents -14.41% |
04:10PM | Fluidigm is Running in Place, but Expects to Break Out in 2020 Motley Fool |
Aug-02-19 01:15PM | Here's Why Fluidigm Is Getting Crushed Today Motley Fool -33.74% |
09:24AM | Fluidigm (FLDM) Q2 2019 Earnings Call Transcript Motley Fool |
12:41AM | CORRECTING and REPLACING - Fluidigm Announces Second Quarter 2019 Financial Results GlobeNewswire |
Aug-01-19 04:05PM | Fluidigm Announces Second Quarter 2019 Financial Results GlobeNewswire |
04:01PM | Jonathan Day Named VP, Commercial Operations, Americas GlobeNewswire |
08:30AM | Fluidigm to Automate RNA Sequencing Library Preparation Using Microfluidics Technology GlobeNewswire |
Jul-30-19 08:30AM | Fluidigm Announces 3rd Annual Imaging Mass Cytometry User Group Meeting GlobeNewswire |
Jul-25-19 10:33AM | Fluidigm (FLDM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks |
08:30AM | Bill W. Colston Named to Fluidigm Board of Directors GlobeNewswire |
Jul-08-19 07:45AM | Update: Fluidigm (NASDAQ:FLDM) Stock Gained 90% In The Last Year Simply Wall St. |
Jul-03-19 01:05PM | Fluidigm Announces Conference Call and Webcast of Second Quarter 2019 Financial Results GlobeNewswire |
Jun-20-19 08:30AM | Fluidigm Highlights New Advancements in Deep Cellular Profiling from Circulation to Tissue at CYTO 2019 GlobeNewswire |
Jun-19-19 08:30AM | Fluidigm Introduces Three Imaging Mass Cytometry Panel Kits and Advanced CyTOF Software to Accelerate Immuno-Oncology Research GlobeNewswire |
Jun-17-19 08:30AM | Fluidigm Scales Highly Multiplexed Cell Analysis with Introduction of Seven New Metal Markers GlobeNewswire |
Jun-04-19 08:30AM | Oncology Researcher Andrew Quong Joins Fluidigm as Chief Science Officer GlobeNewswire |
May-31-19 05:37PM | Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire |
May-29-19 08:45AM | Fluidigm Introduces Advanta RNA Fusions NGS Library Prep Assay to Accelerate Translational and Clinical Cancer Research GlobeNewswire |
08:30AM | Fluidigm Introduces Automated Advanta Solid Tumor NGS Library Prep Assay Using Microfluidics Technology GlobeNewswire |
May-12-19 09:47PM | Hedge Funds Have Never Been This Bullish On Fluidigm Corporation (FLDM) Insider Monkey |
May-10-19 04:05PM | Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire |
May-09-19 08:30AM | Fluidigm to Participate in Upcoming Health Care Investor Conferences GlobeNewswire |
May-06-19 08:00PM | Fluidigm Delivers Growth Where It Matters Most in Q1 2019 Motley Fool |
07:09AM | Edited Transcript of FLDM earnings conference call or presentation 2-May-19 9:00pm GMT Thomson Reuters StreetEvents |
May-04-19 09:15AM | Stocks Soar on Strong Jobs Report; NASDAQ at New High Zacks |
May-03-19 02:38PM | Here's Why Fluidigm Shares Fell as Much as 14.4% Today Motley Fool -13.15% |
01:24AM | Fluidigm (FLDM) Q1 2019 Earnings Call Transcript Motley Fool |
May-02-19 08:35PM | Fluidigm (FLDM) Reports Q1 Loss, Tops Revenue Estimates Zacks |
07:25PM | Fluidigm: 1Q Earnings Snapshot Associated Press |
04:05PM | Fluidigm Announces First Quarter 2019 Financial Results GlobeNewswire |
04:02PM | Leading Cancer Center in Japan Selects Hyperion Imaging System to Expand Immuno-Oncology Research Studies in Colorectal Cancer GlobeNewswire |
May-01-19 10:26AM | Masimo Gets CE Mark for ANI Module, Enhances Root Platform Zacks |
Apr-30-19 09:00AM | Fluidigm Announces 8th Annual Mass Cytometry Summit GlobeNewswire |
Apr-29-19 09:41AM | Can Mass Cytometry Drive Fluidigm's (FLDM) Q1 Earnings? Zacks |
Apr-25-19 10:34AM | Fluidigm (FLDM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks |
Apr-23-19 06:00AM | What to Watch When Fluidigm Reports Q1 Earnings Motley Fool |
Apr-08-19 03:55PM | How Should Investors Feel About Fluidigm Corporation's (NASDAQ:FLDM) CEO Pay? Simply Wall St. |
02:49PM | 3 Stocks to Hold for the Next 20 Years Motley Fool |
Apr-05-19 09:40AM | Here's Why You Should Invest in DENTSPLY (XRAY) Stock Now Zacks |
Apr-04-19 04:05PM | Fluidigm Announces Conference Call and Webcast of First Quarter 2019 Financial Results GlobeNewswire |
Apr-03-19 10:32AM | AngioDynamics' (ANGO) Q3 Earnings & Revenues Lag Estimates Zacks |
Apr-02-19 10:20AM | Glaukos (GKOS) Banks on Solid Pipeline Amid Stiff Competition Zacks |
10:20AM | AngioDynamics Gets FDA Nod to Begin NanoKnife DIRECT Study Zacks |
Mar-28-19 08:45AM | Fluidigm Showcases New Product Innovations and Research Presentations at the 2019 American Association for Cancer Research (AACR) Meeting GlobeNewswire |
08:30AM | Fluidigm Introduces the First Complete Sample-to-Answer Solution for Deep Immune Profiling by Mass Cytometry GlobeNewswire |
Mar-27-19 09:42AM | Look who leased the top floors of South San Francisco's new biotech highrise American City Business Journals |
Mar-18-19 05:48PM | Fluidigm Corp (FLDM) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com |
Mar-15-19 08:51AM | Fluidigm (FLDM) in Focus: Stock Moves 8% Higher Zacks |
Mar-14-19 11:53AM | Here's Why Fluidigm Rose as Much as 13.4% Today Motley Fool +7.97% |
Mar-12-19 09:54AM | Fluidigm Is Emerging From a Large Base Pattern, So Go Long TheStreet.com |
Mar-08-19 07:47AM | 3 Top Stocks Under $20 Motley Fool |
Mar-05-19 08:30AM | Colin McCracken Joins Fluidigm as Chief Commercial Officer GlobeNewswire |
Feb-22-19 05:30PM | Fluidigm to Participate in Upcoming Investor Conferences GlobeNewswire |
02:33PM | Edited Transcript of FLDM earnings conference call or presentation 7-Feb-19 10:00pm GMT Thomson Reuters StreetEvents |
Feb-19-19 02:00PM | 3 Top Stocks That Aren't on Wall Street's Radar Motley Fool |
08:00AM | Detailed Research: Economic Perspectives on Exxon Mobil, Loxo Oncology, Fluidigm, LHC Group, Ebix, and Omega Flex What Drives Growth in Today's Competitive Landscape GlobeNewswire |
Feb-12-19 07:00PM | Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire |
02:23PM | Fluidigm Corporation (NASDAQ:FLDM): Is It A Good Long Term Opportunity? Simply Wall St. |
Feb-11-19 05:03PM | The 1 Stock I'd Buy Right Now Motley Fool |
Feb-08-19 03:55PM | Here's Why Fluidigm Rose as Much as 14.2% Today Motley Fool +9.36% |
Feb-07-19 08:09PM | Fluidigm Corp (FLDM) Q4 2018 Earnings Conference Call Transcript Motley Fool |
06:50PM | Fluidigm (FLDM) Reports Q4 Loss, Tops Revenue Estimates Zacks |
05:57PM | Fluidigm: 4Q Earnings Snapshot Associated Press |
04:05PM | Fluidigm Announces Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire |
09:00AM | Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations GlobeNewswire |
08:30AM | Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases GlobeNewswire |
Jan-31-19 08:30AM | Fluidigm Introduces REAP-Seq for Multi-Omic Single-Cell Analysis on the C1 GlobeNewswire |
Jan-24-19 07:55AM | Consolidated Research: 2019 Summary Expectations for Marriott International, Calavo Growers, Kinsale Capital Group, Fluidigm, Goldman Sachs BDC, and Stemline Therapeutics Fundamental Analysis, Key Performance Indications GlobeNewswire |
Jan-14-19 04:05PM | Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire |
Jan-08-19 08:30AM | Caprion Biosciences Offers Mass Cytometry CRO Services to Advance Biomarker Discovery and Immune Monitoring GlobeNewswire +5.03% |
Dec-23-18 09:49PM | Do Hedge Funds Love Fluidigm Corporation (FLDM)? Insider Monkey |
Dec-14-18 04:05PM | Fluidigm Announces Closing of Public Offering of 9,372,500 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares GlobeNewswire |
Dec-12-18 01:01AM | Fluidigm Announces Pricing of Public Offering of 8,150,000 Shares of Common Stock GlobeNewswire |
Dec-11-18 04:01PM | Fluidigm Announces Commencement of Public Offering of Common Stock GlobeNewswire |
Dec-10-18 04:23PM | Edited Transcript of FLDM earnings conference call or presentation 1-Nov-18 9:00pm GMT Thomson Reuters StreetEvents |
Dec-05-18 09:15AM | Recent Gains Cut in Half on Trade, Yield Curve Fears Zacks |
Nov-12-18 04:05PM | Fluidigm to Participate in the 30th Annual Piper Jaffray Healthcare Conference GlobeNewswire -5.24% |
|
|
|
 |
Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research in the United States and Europe. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 system, Polaris system, C1 IFCs, and Polaris IFC. It sells instruments and consumables, including IFCs, assays, and reagents to academic institutions, clinical research laboratories, and contract research organizations, as well as biopharmaceutical, biotechnology, and agricultural biotechnology companies. The company sells its products to academic institutions, life sciences, and clinical research laboratories that conduct research, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California. |
 |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Kreger Bradley Allen | SVP, Global Operations | Nov 20 | Option Exercise | 0.00 | 3,125 | 0 | 13,346 | Nov 22 08:43 PM | Linthwaite Stephen Christopher | President & CEO | Nov 20 | Option Exercise | 0.00 | 12,562 | 0 | 183,953 | Nov 22 08:33 PM | Khadder Nicholas | See Remarks | Nov 20 | Option Exercise | 0.00 | 4,901 | 0 | 45,431 | Nov 22 08:30 PM | JOG VIKRAM | CHIEF FINANCIAL OFFICER | Nov 20 | Option Exercise | 0.00 | 4,751 | 0 | 46,376 | Nov 22 08:28 PM | Levin Easterly Partners LLC | Passive Investor | Sep 17 | Sale | 5.40 | 577,197 | 3,116,864 | 6,909,871 | Sep 19 04:27 PM | Levin Easterly Partners LLC | Passive Investor | Sep 11 | Sale | 5.55 | 11,545 | 64,112 | 7,487,068 | Sep 13 04:22 PM | COLELLA SAMUEL D | Director | Aug 27 | Buy | 5.19 | 2,000 | 10,372 | 119,481 | Aug 28 09:13 PM | Linthwaite Stephen Christopher | President & CEO | Aug 23 | Buy | 5.52 | 4,000 | 22,077 | 171,391 | Aug 27 07:58 PM | Linthwaite Stephen Christopher | President & CEO | Aug 20 | Option Exercise | 0.00 | 12,562 | 0 | 173,717 | Aug 22 05:55 PM | JOG VIKRAM | CHIEF FINANCIAL OFFICER | Aug 20 | Option Exercise | 0.00 | 4,751 | 0 | 43,269 | Aug 22 05:54 PM | Kreger Bradley Allen | SVP, Global Operations | Aug 20 | Option Exercise | 0.00 | 3,125 | 0 | 11,302 | Aug 22 05:54 PM | Khadder Nicholas | See Remarks | Aug 20 | Option Exercise | 0.00 | 4,901 | 0 | 42,962 | Aug 22 05:54 PM | Levin Easterly Partners LLC | Passive Investor | Aug 13 | Sale | 7.01 | 151,011 | 1,059,282 | 8,271,611 | Aug 15 05:41 PM | COLELLA SAMUEL D | Director | Aug 08 | Buy | 6.65 | 1,000 | 6,653 | 117,481 | Aug 12 04:57 PM | COLELLA SAMUEL D | Director | Aug 07 | Buy | 6.86 | 1,000 | 6,857 | 116,481 | Aug 08 09:04 PM | Levin Easterly Partners LLC | Passive Investor | Aug 07 | Sale | 6.90 | 129,237 | 892,060 | 9,840,084 | Aug 12 05:05 PM | COLELLA SAMUEL D | Director | Aug 06 | Buy | 7.02 | 8,000 | 56,183 | 115,481 | Aug 08 09:04 PM | Levin Easterly Partners LLC | Passive Investor | Aug 01 | Sale | 12.25 | 1,629 | 19,956 | 9,969,321 | Aug 05 03:59 PM | Levin Easterly Partners LLC | Passive Investor | Jul 29 | Sale | 11.97 | 82,585 | 988,460 | 9,970,950 | Jul 29 04:50 PM | Levin Easterly Partners LLC | Passive Investor | Jul 26 | Sale | 11.92 | 195,982 | 2,335,302 | 10,053,535 | Jul 29 04:50 PM | Levin Easterly Partners LLC | Passive Investor | Jul 25 | Sale | 11.85 | 9,405 | 111,480 | 10,249,517 | Jul 29 04:50 PM | Levin Easterly Partners LLC | Passive Investor | Jul 24 | Sale | 11.78 | 28,090 | 330,999 | 10,258,922 | Jul 24 05:01 PM | Levin Easterly Partners LLC | Passive Investor | Jul 23 | Sale | 11.58 | 18,601 | 215,418 | 10,287,012 | Jul 24 05:01 PM | Levin Easterly Partners LLC | Passive Investor | Jul 22 | Sale | 11.57 | 61,432 | 710,903 | 10,305,613 | Jul 24 05:01 PM | Levin Easterly Partners LLC | Passive Investor | Jul 19 | Sale | 11.50 | 83,728 | 963,123 | 10,367,045 | Jul 19 04:21 PM | Levin Easterly Partners LLC | Passive Investor | Jul 18 | Sale | 11.50 | 179,853 | 2,068,303 | 10,450,773 | Jul 19 04:21 PM | Levin Easterly Partners LLC | Passive Investor | Jul 17 | Sale | 11.32 | 134,487 | 1,522,178 | 10,630,626 | Jul 19 04:21 PM | Levin Easterly Partners LLC | Passive Investor | Jul 01 | Sale | 12.33 | 29,410 | 362,771 | 10,765,113 | Jul 02 04:35 PM | Levin Easterly Partners LLC | Passive Investor | Jun 28 | Sale | 12.30 | 157,349 | 1,935,487 | 10,794,523 | Jul 02 04:35 PM | Levin Easterly Partners LLC | Passive Investor | Jun 25 | Sale | 12.23 | 25,452 | 311,387 | 10,951,872 | Jun 27 06:04 PM | Levin Easterly Partners LLC | Passive Investor | Jun 24 | Sale | 12.29 | 191,696 | 2,355,273 | 10,976,694 | Jun 27 06:04 PM | COLELLA SAMUEL D | Director | Jun 20 | Option Exercise | 6.13 | 23,600 | 144,762 | 107,481 | Jun 24 09:14 PM | BARTHELEMY NICOLAS | Director | Jun 17 | Sale | 12.43 | 5,100 | 63,398 | 41,849 | Jun 19 04:36 PM | Khadder Nicholas | See Remarks | May 20 | Option Exercise | 0.00 | 4,901 | 0 | 39,725 | May 22 09:01 PM | JOG VIKRAM | CHIEF FINANCIAL OFFICER | May 20 | Option Exercise | 0.00 | 4,751 | 0 | 40,162 | May 22 09:02 PM | Kreger Bradley Allen | SVP, Global Operations | May 20 | Option Exercise | 0.00 | 12,500 | 0 | 12,500 | May 22 09:00 PM | Linthwaite Stephen Christopher | President & CEO | May 20 | Option Exercise | 0.00 | 12,562 | 0 | 164,020 | May 22 09:01 PM | BARTHELEMY NICOLAS | Director | Mar 23 | Option Exercise | 0.00 | 2,500 | 0 | 42,962 | Mar 26 05:49 PM | Paya Carlos V | Director | Mar 23 | Option Exercise | 0.00 | 2,500 | 0 | 36,856 | Mar 26 05:49 PM | Linthwaite Stephen Christopher | President & CEO | Feb 20 | Option Exercise | 0.00 | 12,562 | 0 | 156,102 | Feb 21 09:10 PM | Khadder Nicholas | See Remarks | Feb 20 | Option Exercise | 0.00 | 4,901 | 0 | 36,829 | Feb 21 09:09 PM | McPhail Steven | Chief Commercial Officer | Feb 20 | Option Exercise | 0.00 | 3,722 | 0 | 58,417 | Feb 21 09:08 PM | JOG VIKRAM | CHIEF FINANCIAL OFFICER | Feb 20 | Option Exercise | 0.00 | 4,952 | 0 | 37,421 | Feb 21 09:08 PM | LEVIN CAPITAL STRATEGIES, L.P. | Passive Investor | Dec 24 | Buy | 7.79 | 85 | 662 | 10,473,809 | Dec 26 03:40 PM | LEVIN CAPITAL STRATEGIES, L.P. | Passive Investor | Dec 20 | Buy | 7.42 | 576 | 4,273 | 10,413,365 | Dec 26 03:40 PM | LEVIN CAPITAL STRATEGIES, L.P. | Passive Investor | Dec 19 | Buy | 7.86 | 128 | 1,006 | 10,412,789 | Dec 20 05:07 PM | LEVIN CAPITAL STRATEGIES, L.P. | Passive Investor | Dec 18 | Buy | 7.71 | 36 | 278 | 10,412,661 | Dec 20 05:07 PM | LEVIN CAPITAL STRATEGIES, L.P. | Passive Investor | Dec 14 | Buy | 7.81 | 41 | 320 | 10,412,625 | Dec 18 03:09 PM | LEVIN CAPITAL STRATEGIES, L.P. | Passive Investor | Dec 12 | Buy | 6.75 | 1,000,000 | 6,750,000 | 10,404,641 | Dec 14 06:14 PM | LEVIN CAPITAL STRATEGIES, L.P. | Passive Investor | Dec 10 | Buy | 7.72 | 35,000 | 270,200 | 9,970,342 | Dec 11 03:26 PM |
|
 |
|
 |
|